Treatment of pediatric psoriasis with TNF-antagonists : a real-life single-center case series
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:97 |
|---|---|
| Enthalten in: |
Anais brasileiros de dermatologia - 97(2022), 6 vom: 05. Nov., Seite 819-822 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Megna, Matteo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adalimumab |
|---|
| Anmerkungen: |
Date Completed 18.10.2022 Date Revised 10.11.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.abd.2021.10.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM345852427 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345852427 | ||
| 003 | DE-627 | ||
| 005 | 20231226030026.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.abd.2021.10.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1152.xml |
| 035 | |a (DE-627)NLM345852427 | ||
| 035 | |a (NLM)36068092 | ||
| 035 | |a (PII)S0365-0596(22)00182-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Megna, Matteo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of pediatric psoriasis with TNF-antagonists |b a real-life single-center case series |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.10.2022 | ||
| 500 | |a Date Revised 10.11.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Tumor Necrosis Factor Inhibitors |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
| 650 | 7 | |a Infliximab |2 NLM | |
| 650 | 7 | |a B72HH48FLU |2 NLM | |
| 650 | 7 | |a Adalimumab |2 NLM | |
| 650 | 7 | |a FYS6T7F842 |2 NLM | |
| 650 | 7 | |a Etanercept |2 NLM | |
| 650 | 7 | |a OP401G7OJC |2 NLM | |
| 700 | 1 | |a Fabbrocini, Gabriella |e verfasserin |4 aut | |
| 700 | 1 | |a Gallo, Lucia |e verfasserin |4 aut | |
| 700 | 1 | |a Ruggiero, Angelo |e verfasserin |4 aut | |
| 700 | 1 | |a Camela, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Ocampo-Garza, Sonia Sofía |e verfasserin |4 aut | |
| 700 | 1 | |a Cinelli, Eleonora |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anais brasileiros de dermatologia |d 1963 |g 97(2022), 6 vom: 05. Nov., Seite 819-822 |w (DE-627)NLM040896307 |x 1806-4841 |7 nnns |
| 773 | 1 | 8 | |g volume:97 |g year:2022 |g number:6 |g day:05 |g month:11 |g pages:819-822 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.abd.2021.10.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 97 |j 2022 |e 6 |b 05 |c 11 |h 819-822 | ||